Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CI 
Cigna Corp (CI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/29/2025: CI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
25 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $366.5
1 Year Target Price $366.5
| 13 | Strong Buy |
| 6 | Buy |
| 6 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -7.83% | Avg. Invested days 37 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/29/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 82.32B USD | Price to earnings Ratio 16.92 | 1Y Target Price 366.5 |
Price to earnings Ratio 16.92 | 1Y Target Price 366.5 | ||
Volume (30-day avg) 25 | Beta 0.46 | 52 Weeks Range 255.60 - 346.57 | Updated Date 10/29/2025 |
52 Weeks Range 255.60 - 346.57 | Updated Date 10/29/2025 | ||
Dividends yield (FY) 1.88% | Basic EPS (TTM) 18.23 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-30 | When Before Market | Estimate 7.69 | Actual - |
Profitability
Profit Margin 1.92% | Operating Margin (TTM) 3.67% |
Management Effectiveness
Return on Assets (TTM) 3.98% | Return on Equity (TTM) 13.18% |
Valuation
Trailing PE 16.92 | Forward PE 9.14 | Enterprise Value 105711299713 | Price to Sales(TTM) 0.31 |
Enterprise Value 105711299713 | Price to Sales(TTM) 0.31 | ||
Enterprise Value to Revenue 0.41 | Enterprise Value to EBITDA - | Shares Outstanding 266928075 | Shares Floating 265630805 |
Shares Outstanding 266928075 | Shares Floating 265630805 | ||
Percent Insiders 1.59 | Percent Institutions 89.9 |
Upturn AI SWOT
Cigna Corp
Company Overview
History and Background
Cigna was formed in 1982 through the merger of the Connecticut General Life Insurance Company (CG) and INA Corporation (Insurance Company of North America). CG was founded in 1865, and INA in 1792. Since then, Cigna has grown through acquisitions and organic growth, becoming a major player in the health insurance and related services market.
Core Business Areas
- Evernorth Health Services: This segment includes pharmacy benefits management (PBM) through Express Scripts, specialty pharmacy services, care delivery and management, and intelligence solutions.
- Cigna Healthcare: This segment provides medical, pharmacy, behavioral health, dental, and vision benefits to employers, individuals, and Medicare and Medicaid customers.
- International Health: This segment offers health care coverage and related services to globally mobile individuals and businesses, as well as local nationals in select countries.
Leadership and Structure
Cigna Corp is led by David Cordani as Chairman and CEO. The organizational structure includes various executive leadership positions overseeing different business segments and functional areas such as finance, human resources, and technology.
Top Products and Market Share
Key Offerings
- Pharmacy Benefits Management (PBM): Through Express Scripts, Cigna manages prescription drug benefits for employers and health plans. PBMs negotiate drug prices, manage formularies, and process claims. Competitors include CVS Health (CVS) and UnitedHealth Group (UNH) through OptumRx. Revenue attributed to Express Scripts is a significant portion of Evernorth's revenues. Market share of overall PBM market varies from 20-25% in the overall market.
- Medicare Advantage Plans: Cigna offers Medicare Advantage plans to seniors, providing comprehensive health coverage, including medical, prescription drug, and often dental and vision benefits. Competitors include UnitedHealth Group (UNH), Humana (HUM), and CVS Health (CVS). Data about the number of users or market share is difficult to isolate.
- Group Health Insurance: Cigna provides group health insurance plans to employers of all sizes. These plans cover medical, dental, and vision care for employees and their dependents. Key competitors include UnitedHealth Group (UNH), Anthem (ANTM), and Aetna (CVS). Market share of overall group health market varies from 10-15% in the overall market.
Market Dynamics
Industry Overview
The health insurance industry is highly competitive and regulated. It faces pressures from rising healthcare costs, changing demographics, and evolving government policies such as the Affordable Care Act. Consolidation among providers and insurers is a continuing trend.
Positioning
Cigna is a diversified health services company, operating as both an insurer and a provider of healthcare services. Its strength lies in its integrated model, which allows it to manage costs and improve quality of care. It has a strong presence in both domestic and international markets.
Total Addressable Market (TAM)
The total addressable market for health insurance and related services is estimated to be in the trillions of dollars globally. Cigna is positioned to capture a significant share of this market through its diversified offerings and integrated approach. Cigna's TAM is about 15% of the total Health and Pharmaceutical market.
Upturn SWOT Analysis
Strengths
- Diversified business model (insurance and services)
- Strong brand recognition
- Global presence
- Integrated healthcare delivery model
- Strong financial performance
Weaknesses
- Exposure to regulatory changes
- Dependence on key partnerships
- Integration risks from acquisitions
- Negative customer relations
- Cybersecurity risks and data protection
Opportunities
- Growing demand for health insurance in emerging markets
- Expansion of telehealth and digital health services
- Increased focus on preventive care
- Acquisition opportunities to expand market share
- Opportunities to partner with healthcare providers to offer integrated care solutions
Threats
- Increased competition from other health insurers
- Rising healthcare costs
- Changes in government regulations
- Cybersecurity threats
- Economic downturn
Competitors and Market Share
Key Competitors
- UNH
- ANTM
- HUM
- CVS
Competitive Landscape
Cigna competes with other large health insurers, PBMs, and healthcare providers. Cigna's competitive advantages include its diversified business model, integrated healthcare delivery model, and global presence. However, it faces challenges from competitors with larger market shares and greater brand recognition.
Major Acquisitions
Express Scripts
- Year: 2018
- Acquisition Price (USD millions): 54000
- Strategic Rationale: The acquisition of Express Scripts expanded Cigna's capabilities in pharmacy benefits management, creating a more integrated healthcare delivery model. The combination also allows Cigna to better manage healthcare costs and improve quality of care.
Growth Trajectory and Initiatives
Historical Growth: Cigna has achieved consistent revenue and earnings growth through organic growth and strategic acquisitions.
Future Projections: Analysts project continued revenue and earnings growth for Cigna, driven by increasing demand for health insurance and related services. Growth of 5-7% is expected over the next 3 years.
Recent Initiatives: Recent strategic initiatives include expanding its Medicare Advantage offerings, investing in digital health technologies, and focusing on value-based care arrangements.
Summary
Cigna Corporation demonstrates a robust and diversified healthcare model, with significant strengths in its integrated services and global reach. The company has shown steady growth and strong shareholder returns; however, it must navigate regulatory changes and increasing competition. Opportunities lie in emerging markets and digital health, while ongoing threats include rising healthcare costs and cybersecurity. The company needs to be aware of customer satisfaction and debt management.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Market Research Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. The data and analysis are based on publicly available information and may not be complete or accurate. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cigna Corp
Exchange NYSE | Headquaters Bloomfield, CT, United States | ||
IPO Launch date 1982-03-31 | CEO & Chair of the Board Mr. David Michael Cordani | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 71295 | Website https://www.cigna.com |
Full time employees 71295 | Website https://www.cigna.com | ||
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.